FDA
-
-
-
-
-
-
-
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
-
-
-
-
-
-
-
NurExone’s Intellectual Property Portfolio Expands
-
-
-
-
-
-
322,953 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

